← Browse by Condition
Medical Condition

intratumoral injection

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05838729 Phase 1, Phase 2
Recruiting

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

Enrollment
16 pts
Location
United States
Sponsor
Coordination Pharmaceuticals, ...
View Trial →